Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Exact Sciences Cor (EXAS) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 1,506,900
  • Shares Outstanding, K 108,410
  • Annual Sales, $ 39,440 K
  • Annual Income, $ -157,800 K
  • 36-Month Beta 0.87
  • Price/Sales 38.21
  • Price/Book 4.16

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.35 +7.28%
on 12/02/16
18.72 -23.49%
on 11/09/16
-2.09 (-12.72%)
since 11/07/16
3-Month
13.35 +7.28%
on 12/02/16
22.21 -35.52%
on 09/22/16
-5.11 (-26.29%)
since 09/07/16
52-Week
4.67 +206.68%
on 03/01/16
22.80 -37.18%
on 08/15/16
+6.10 (+74.23%)
since 12/07/15

Most Recent Stories

More News
Technical Reports on Healthcare Stocks -- Exact Sciences, Agilent Technologies, Hill-Rom, and Waters

Today, Stock-Callers.com has issued research reports on: Exact Sciences Corp. (NASDAQ: EXAS), Agilent Technologies Inc. (NYSE: A), Hill-Rom Holdings Inc. (NYSE: HRC), and Waters Corp. (NYSE: WAT). These...

Exact Sciences Appoints Jeff Elliott Chief Financial Officer

Exact Sciences Corp. (Nasdaq: EXAS) today announced the appointment of Jeff Elliott as chief financial officer. Mr. Elliott, a former senior research analyst at Robert W. Baird & Co., joined Exact Sciences...

Exact Sciences to participate in November investor conferences

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in three investor conferences during November.

EXACT Sciences Becomes Oversold (EXAS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

Exact Sciences' Cologuard Wins Prestigious Prix Galien Award for Best Medical Technology Product

Exact Sciences Corp. (NASDAQ: EXAS) today announced that Cologuard, the first and only FDA-approved noninvasive, stool DNA-based colorectal cancer screening test, has won the 2016 10th Annual Prix Galien...

Exact Sciences Completes 68,000 Cologuard Tests During the Third Quarter

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $28.1 million during the third quarter ended Sept. 30, 2016, an increase of 123 percent from $12.6 million in...

Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More

How will these four drug stocks, BIIB, EXAS, MDCO and ANIK, which are scheduled to report Q3 results on Oct 26, fare this earnings season?

Healthcare Stocks on Investors' Radar -- Exact Sciences, Great Basin Scientific, Agilent Technologies, and Neogenomics

On Wednesday, the US markets continues on the previous day's bullish trend as the NASDAQ Composite ended the trading session up 0.05%; the Dow Jones Industrial Average edged 0.22% higher; and the S&P 500...

Cologuard® Covered for TRICARE Beneficiaries

Exact Sciences Corp. (Nasdaq: EXAS) today announced that Cologuard® is now covered under TRICARE's preventive services policies for use every three years without patient coinsurance, copayments or deductibles....

The Top 100 U.S. In-Vitro Diagnostics Companies

Did you know?

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in...

See More

Support & Resistance

2nd Resistance Point 15.31
1st Resistance Point 14.97
Last Price 14.43
1st Support Level 13.98
2nd Support Level 13.33

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.